Small Pharma's DMT-assisted therapy (SPL026) demonstrated to be well-tolerated and safe in psychedelic naïve volunteers
Dataset generated from Phase I enables the selection of the optimal dose...
Every successful drug was once in Phase I.
"In previously published non-controlled studies, ibogaine has demonstrated rapid and sustained efficacy in treating OUD and has the...
The AdvisorShares Psychedelics ETF (NYSE ticker: PSIL) invests in the emerging psychedelic drugs sector, offering exposure to those biotechnology, pharmaceutical and life sciences companies we see as leading the way in this...
atai Life Sciences Increases Loan in Principal by US$6m to Support IntelGenx’s Graduation to Toronto Stock Exchange After Positive Early Feasibility Study Data
LIVE QUOTE...
(CSE: NM)
TORONTO, ON / ACCESSWIRE / September 20, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased...
The presentations from their recent live event are now available for replay. The event featured CEOs and top executives from international companies engaged in a wide range of initiatives across the...
